These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 20952439)

  • 21. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
    Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
    Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis.
    Mubarak KK; Montes-Worboys A; Regev D; Nasreen N; Mohammed KA; Faruqi I; Hensel E; Baz MA; Akindipe OA; Fernandez-Bussy S; Nathan SD; Antony VB
    Eur Respir J; 2012 Jan; 39(1):133-40. PubMed ID: 21737551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease].
    Yoshimura K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():20-31. PubMed ID: 8007466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis.
    Cao B; Guo Z; Zhu Y; Xu W
    Chin Med J (Engl); 2000 Sep; 113(9):776-82. PubMed ID: 11776068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New pharmacological strategies for the treatment of pulmonary fibrosis.
    Gogali A; Wells AU
    Ther Adv Respir Dis; 2010 Dec; 4(6):353-66. PubMed ID: 20864457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of idiopathic pulmonary fibrosis: from initial apoptosis of epithelial cells to lung remodeling?
    Jin HL; Dong JC
    Chin Med J (Engl); 2011 Dec; 124(24):4330-8. PubMed ID: 22340409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.
    Yamaguchi M; Hirai S; Tanaka Y; Sumi T; Miyajima M; Mishina T; Yamada G; Otsuka M; Hasegawa T; Kojima T; Niki T; Watanabe A; Takahashi H; Sakuma Y
    Lab Invest; 2017 Mar; 97(3):232-242. PubMed ID: 27941755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1).
    Warshamana GS; Corti M; Brody AR
    Exp Mol Pathol; 2001 Aug; 71(1):13-33. PubMed ID: 11502094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β activation and lung fibrosis.
    Tatler AL; Jenkins G
    Proc Am Thorac Soc; 2012 Jul; 9(3):130-6. PubMed ID: 22802287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of non-coding RNA signatures in idiopathic pulmonary fibrosis.
    Elek A; Bozgeyik E; Caska H; Gocer Z; Bozgeyik I
    Ir J Med Sci; 2024 Aug; 193(4):1923-1927. PubMed ID: 38523167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic pulmonary fibrosis.
    Hoo ZH; Whyte MK
    Thorax; 2012 Aug; 67(8):742-6. PubMed ID: 21697287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer.
    Williams AO; Flanders KC; Saffiotti U
    Am J Pathol; 1993 Jun; 142(6):1831-40. PubMed ID: 8389528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis.
    Calabrese F; Lunardi F; Balestro E; Marulli G; Perissinotto E; Loy M; Nannini N; Valente M; Saetta M; Agostini C; Rea F
    Pathology; 2012 Apr; 44(3):192-8. PubMed ID: 22406480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.
    Selman M; Pardo A
    Proc Am Thorac Soc; 2006 Jun; 3(4):364-72. PubMed ID: 16738202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New perspectives in the treatment of idiopathic pulmonary fibrosis.
    Rogliani P; Mura M; Assunta Porretta M; Saltini C
    Ther Adv Respir Dis; 2008 Apr; 2(2):75-93. PubMed ID: 19124361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis.
    Selman M; López-Otín C; Pardo A
    Eur Respir J; 2016 Aug; 48(2):538-52. PubMed ID: 27390284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Potential role of cytokines in idiopathic pulmonary fibrosis].
    Wu XM; Wang XY; Chen FH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jun; 15(6):362-4. PubMed ID: 12837171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
    Cosgrove GP; Brown KK; Schiemann WP; Serls AE; Parr JE; Geraci MW; Schwarz MI; Cool CD; Worthen GS
    Am J Respir Crit Care Med; 2004 Aug; 170(3):242-51. PubMed ID: 15117744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal.
    Wynes MW; Frankel SK; Riches DW
    J Leukoc Biol; 2004 Nov; 76(5):1019-27. PubMed ID: 15316031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.